Minimally invasive hybrid surgery: A salvage tumor enucleation for local recurrence of thoracic esophageal carcinoma after definitive chemoradiotherapy

Asian J Endosc Surg. 2021 Jan;14(1):77-80. doi: 10.1111/ases.12830. Epub 2020 Jul 6.

Abstract

Local recurrence after definitive chemoradiation for esophageal carcinoma is associated with poor outcomes. Although salvage esophagectomy is a standard treatment that offers a chance of long-term survival, the procedure is associated with high morbidity and mortality. Minimally invasive hybrid surgery (MIHS) employs thoracoscopic and esophagoscopic procedures and is generally used to treat benign esophageal submucosal tumors. A 64-year-old man with thoracic esophageal carcinoma experienced local relapse after definitive chemoradiation. He underwent MIHS and was discharged 18 days after surgery with a slight degree of stricture. Pathological findings revealed squamous cell carcinoma with no residual tumor in the resection margins, and the patient remains free from cancer relapse 24 months after surgery. Here, we report the findings in this patient, in whom MIHS was successfully performed as a salvage tumor enucleation for local recurrence of esophageal carcinoma after definitive chemoradiotherapy.

Keywords: esophageal squamous cell carcinoma; local neoplasm recurrence; minimally invasive surgery.

Publication types

  • Case Reports

MeSH terms

  • Chemoradiotherapy*
  • Esophageal Neoplasms* / surgery
  • Esophageal Squamous Cell Carcinoma / surgery*
  • Esophagectomy* / methods
  • Humans
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures / methods
  • Neoplasm Recurrence, Local* / surgery
  • Retrospective Studies
  • Salvage Therapy
  • Treatment Outcome